Literature DB >> 9437277

Rate of RhD sensitisation before and after implementation of a community based antenatal prophylaxis programme.

S Mayne1, J H Parker, T A Harden, S D Dodds, J A Beale.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9437277      PMCID： PMC2127978          DOI： 10.1136/bmj.315.7122.1588

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  12 in total

1.  Survey on the prevention and incidence of haemolytic disease of the newborn in Italy.

Authors:  Francesco Bennardello; Giuseppe Curciarello
Journal:  Blood Transfus       Date:  2013-06-14       Impact factor: 3.443

Review 2.  The role of antenatal immunoprophylaxis in the prevention of maternal-foetal anti-Rh(D) alloimmunisation.

Authors:  Giancarlo Maria Liumbruno; Angelo D'Alessandro; Federica Rea; Vanessa Piccinini; Liviana Catalano; Gabriele Calizzani; Simonetta Pupella; Giuliano Grazzini
Journal:  Blood Transfus       Date:  2010-01       Impact factor: 3.443

3.  Preventing RhD haemolytic disease of the newborn. RhD negative women who have intrauterine death may need anti-D immunoglobulin.

Authors:  R Fox
Journal:  BMJ       Date:  1998-04-11

4.  Recommendations for the prevention and treatment of haemolytic disease of the foetus and newborn.

Authors:  Francesco Bennardello; Serelina Coluzzi; Giuseppe Curciarello; Tullia Todros; Stefania Villa
Journal:  Blood Transfus       Date:  2015-01       Impact factor: 3.443

5.  Prenatal RhD Testing: A Review of Studies Published from 2006 to 2008.

Authors:  Tobias Jörg Legler; Sina Patricia Müller; Alexander Haverkamp; Simon Grill; Sinuhe Hahn
Journal:  Transfus Med Hemother       Date:  2009-05-14       Impact factor: 3.747

6.  PURL: A new protocol for RhD-negative pregnant women?

Authors:  Corey Lyon; Aimee English
Journal:  J Fam Pract       Date:  2018-05       Impact factor: 0.493

7.  A new fetal RHD genotyping test: costs and benefits of mass testing to target antenatal anti-D prophylaxis in England and Wales.

Authors:  Ala Szczepura; Leeza Osipenko; Karoline Freeman
Journal:  BMC Pregnancy Childbirth       Date:  2011-01-18       Impact factor: 3.007

8.  Routine antenatal anti-D prophylaxis in women who are Rh(D) negative: meta-analyses adjusted for differences in study design and quality.

Authors:  Rebecca M Turner; Myfanwy Lloyd-Jones; Dilly O C Anumba; Gordon C S Smith; David J Spiegelhalter; Hazel Squires; John W Stevens; Michael J Sweeting; Stanislaw J Urbaniak; Robert Webster; Simon G Thompson
Journal:  PLoS One       Date:  2012-02-03       Impact factor: 3.240

9.  Bias modelling in evidence synthesis.

Authors:  Rebecca M Turner; David J Spiegelhalter; Gordon C S Smith; Simon G Thompson
Journal:  J R Stat Soc Ser A Stat Soc       Date:  2009-01       Impact factor: 2.483

Review 10.  Appropriate provision of anti-D prophylaxis to RhD negative pregnant women: a scoping review.

Authors:  Trina M Fyfe; M Jane Ritchey; Christorina Taruc; Daniel Crompton; Brian Galliford; Rose Perrin
Journal:  BMC Pregnancy Childbirth       Date:  2014-12-10       Impact factor: 3.007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.